GlassScriptPhysician profile
Kody James Nilsson
NPI 1609226737
$972.43
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.06 · 2020: $328 · 2021: $551 · 2022: $13.07.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $240.48 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $141.96 | 2019-2021 | |
| Abbvie INC. | $136.65 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.57 | 2019-2021 | |
| Novo Nordisk INC | $89.81 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $39.27 | 2020-2021 | |
| Nevro Corp. | $36.26 | 2021 | |
| Allergan, INC. | $35.01 | 2020-2021 | |
| Amarin Pharma, INC. | $31.77 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $27.60 | 2020-2021 | |
| Amgen INC. | $24.96 | 2020-2021 | |
| Glaxosmithkline, LLC. | $24.35 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.34 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.34 | 2021 | |
| Tactile Systems Technology INC | $13.31 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $11.75 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kody Nilsson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.